Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays

ABSTRACT The implementation of antiretroviral therapy demands the need for increased access to viral load (VL) monitoring. Newer real-time VL testing technologies are faster and have larger dynamic ranges and fully automated extraction to benefit higher throughputs in resource-poor environments. The Abbott RealTime human immunodeficiency virus type 1 (HIV-1) assay was evaluated as a new option for testing for HIV-1 subtype C in South Africa, and its performance was compared to the performance of existing assays (the Cobas AmpliPrep-Cobas TaqMan HIV-1, version 1, assay; the AmpliPrep-Cobas Monitor standard HIV-1 assay; and the NucliSENS EasyQ-EasyMag HIV-1 assay) in a high-throughput laboratory. The total precision of the RealTime HIV-1 assay was acceptable over all viral load ranges. This assay compared most favorably with the Cobas AmpliPrep-Cobas TaqMan HIV-1 assay (R2 = 0.904), with a low standard deviation of difference being detected (0.323 copies/ml). The bias against comparator assays ranged from −0.001 copies/ml to −0.228 copies/ml. Variability in the reporting of VLs for a 20-member subtype panel compared to the variability of other assays was noted with subtypes G and CRF02-AG. The RealTime HIV-1 assay can test 93 samples per day with minimal manual preparation, less staff, and the minimization of contamination through automation. This assay is suitable for HIV-1 subtype C VL quantification in South Africa.

[1]  R. Badaró,et al.  Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. , 2006, Journal of virological methods.

[2]  F. Wiesmann,et al.  Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine , 2007, Clinical chemistry and laboratory medicine.

[3]  A. Geretti,et al.  Comparative Evaluation of the Performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) Assay for Measurement of HIV-1 Plasma Viral Load following Automated Specimen Preparation , 2006, Journal of Clinical Microbiology.

[4]  Youchun Wang,et al.  Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in China. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  Deborah K Glencross,et al.  Multiple method comparison: Statistical model using percentage similarity , 2003, Cytometry. Part B, Clinical cytometry.

[6]  G. Yılmaz.  Diagnosis of HIV infection and laboratory monitoring of its therapy. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  F. Brun-Vézinet,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays , 2007, Journal of Clinical Microbiology.

[8]  V. Ferré,et al.  Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. , 2005, Journal of virological methods.

[9]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[10]  Gavin Cloherty,et al.  Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR , 2007, Nucleic acids research.

[11]  J. Albert,et al.  Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the amplicor HIV-1 monitor assay. , 1999, AIDS research and human retroviruses.

[12]  K. Luk,et al.  Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets. , 2007, Journal of virological methods.

[13]  V. Soriano,et al.  Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. , 2007, Journal of virological methods.

[14]  T. Leitner,et al.  Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2005, Journal of medical virology.

[15]  L. Scott,et al.  Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. , 2005, Journal of virological methods.

[16]  Wolfram Schumacher,et al.  Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[18]  J. Pawlotsky,et al.  Multicenter Performance Evaluation of a New TaqMan PCR Assay for Monitoring Human Immunodeficiency Virus RNA Load , 2006, Journal of Clinical Microbiology.

[19]  V. Soriano,et al.  Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT , 2005, Journal of Clinical Microbiology.

[20]  L. Scott,et al.  Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South Africa , 2005, Journal of Clinical Microbiology.

[21]  Sanjay Tyagi,et al.  Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.

[22]  B. Diedrich,et al.  Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2007, Journal of Clinical Microbiology.

[23]  Cheryl Jennings,et al.  HIV-1 Viral Load Assays for Resource-Limited Settings , 2006, PLoS medicine.

[24]  Z. Grossman,et al.  Comparative performance of the Amplicor HIV‐1 monitor assay versus NucliSens EasyQ in HIV subtype C‐infected patients , 2006, Journal of medical virology.

[25]  Christian Drosten,et al.  Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5′ Long Terminal Repeat Domain , 2006, Clinical chemistry.

[26]  F. Kramer,et al.  Thermodynamic basis of the enhanced specificity of structured DNA probes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Makadzange,et al.  Scaling up ART treatment capacity: Lessons learned from South Africa, Zimbabwe, and Botswana , 2008, Current HIV/AIDS Reports.

[28]  L. Scott,et al.  Evaluation of the Performance of the Automated NucliSENS easyMAG and EasyQ Systems versus the Roche AmpliPrep-AMPLICOR Combination for High-Throughput Monitoring of Human Immunodeficiency Virus Load , 2007, Journal of Clinical Microbiology.

[29]  A. Gerritzen,et al.  Comparison of the Roche COBAS Amplicor™ Monitor, Roche COBAS Ampliprep™/COBAS Taqman™ and Abbott RealTime™ Test assays for quantification of hepatitis C virus and HIV RNA , 2007, Clinical chemistry and laboratory medicine.

[30]  J. Hackett,et al.  Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. , 2006, Journal of virological methods.

[31]  T. Bourlet,et al.  Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes , 2007, Journal of acquired immune deficiency syndromes.

[32]  G. Schochetman,et al.  Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. , 2000, Journal of virological methods.

[33]  D. Martin.  Appropriate laboratory monitoring of HIV. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[34]  D. Clark,et al.  Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay , 2007, Journal of Clinical Microbiology.

[35]  H. Niesters,et al.  Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[36]  J. Peter,et al.  Monitoring HIV viral loads in the United States: recent trends and methodologies. , 2002, Journal of acquired immune deficiency syndromes.

[37]  L. Myer,et al.  Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[38]  B. Griffith,et al.  Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT). , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[39]  H. Doerr,et al.  Molecular assays for monitoring HIV infection and antiretroviral therapy , 2007, Expert review of molecular diagnostics.